At MedDay, we believe that it is possible to treat neurodegenerative diseases by targeting key neurometabolic pathways.
We strive to develop neuro repair disease modifying therapies and to provide solutions to patients, their caregivers and the healthcare community, in order to improve patient care in areas of high unmet medical need.
Promising clinical trial outcomes have encouraged us to date, and are continuing to drive us to pursue this direction.
In daring to explore disrupted metabolic pathways in the central nervous system, our teams push the limits to improve future treatment options for people affected by neurodegenerative diseases.
Our Vision: When you explore new angles, you discover new horizons
- To transform the lives of people living with serious neurodegenerative diseases by investigating brain metabolism to generate a robust pipeline of therapies
- To become a fully integrated biopharmaceutical company that brings innovative products to people with severe neurodegenerative disorders
Our cultural DNA
A company’s culture starts on Day One. Our core values are part of the company’s DNA and are essential to our identity.
In our day-to-day life at MedDay, we are driven by excellence and guided by the following values:
We choose to speak openly and truthfully even if this leads to healthy conflict. We act with integrity
As the company grows, we will continue to focus on our main priority which is to provide hope and medicines to our patients
Pioneering and driven by challenges, through brain metabolism, we have a fundamentally new approach to treat nervous system disorders. We are proactive, think outside the box and challenge the status quo
We are always willing to learn and we are open to exploring different ideas
United by a common goal, we leverage the power of working together to achieve a greater outcome